Michelle Finnegan

Statistics

Publications

Citations

2.2K

H-Index

Active since

1984

Affiliations

Albert Einstein College of Medicine(Current)

AbbVie (United States)

Georgetown University

King's College London

Allergan (United States)

Michelle Finnegan is an author at Albert Einstein College of Medicine specializing in migraine pharmacotherapy, migraine pharmacology, and pharmacotherapy.

ORCID

Publications per year

1984–2023

Publications

The sick building syndrome: prevalence studies.

Michelle Finnegan, Christopher Pickering, Sherwood Burge · BMJ · 1984 · 377 citations · Full text

Public Health, Health Sciences, Air Conditioning +14

Ubrogepant for the Treatment of Migraine

David W. Dodick, Richard B. Lipton, Jessica Ailani et al. · New England Journal of Medicine · 2019 · 347 citations

Medicine, Pharmacology, Pharmacotherapy +17

Atogepant for the Preventive Treatment of Migraine

Jessica Ailani, Richard B. Lipton, Peter J. Goadsby et al. · New England Journal of Medicine · 2021 · 310 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine

Richard B. Lipton, David W. Dodick, Jessica Ailani et al. · JAMA · 2019 · 276 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

Patricia Pozo‐Rosich, Jessica Ailani, Messoud Ashina et al. · The Lancet · 2023 · 133 citations

Medicine, Neurology, Preventive Medicine +9

1–5 of 22